SCHEDULE 13G/A: Alger Associates Discloses 5.2% Stake in Cryoport, Inc.

Alger Associates, Inc. has filed an amended Schedule 13G, reporting a 5.2% beneficial ownership stake in Cryoport, Inc. as of December 31, 2024.

Summary

• Alger Associates, Inc. has filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Cryoport, Inc.
• The filing indicates that Alger Associates, Inc. beneficially owns 2,566,937 shares of Cryoport, Inc. Common Stock.
• This ownership represents 5.2% of the class of securities.
• Alger Associates, Inc. holds sole voting power and sole dispositive power over all 2,566,937 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Cryoport, Inc.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as the filing indicates an institutional investor has taken a significant stake, which can be viewed as a vote of confidence. However, it's a routine disclosure and doesn't contain operational or financial performance details.

Positives

• The disclosure of a significant stake by an institutional investor like Alger Associates, Inc. can signal confidence in Cryoport, Inc.'s prospects.
• The acquisition of shares was stated to be in the ordinary course of business, indicating a long-term investment perspective rather than an activist intent.

Risks

• The filing itself does not present risks to Cryoport, Inc.; rather, it is a disclosure of an investment stake. The primary risk for the investor (Alger Associates) would be the market performance of Cryoport, Inc. shares.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of beneficial ownership by an institutional investor in a publicly traded company. It reflects an investment decision by Alger Associates, Inc. in Cryoport, Inc., a company operating in the specialized field of temperature-controlled supply chain solutions for the life sciences industry. Such disclosures are common and provide transparency regarding significant institutional holdings.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may increase investor confidence and potentially attract further institutional interest.
• Company Management: Awareness of a significant shareholder may influence strategic decisions, though the filing explicitly states the stake is not for control purposes.

Key Dates

Keywords

Cryoport Inc., Alger Associates Inc., Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Institutional Investor, Investment Management, Biologistics